These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16400829)
1. Human immune studies in multiple sclerosis. Bar-Or A Adv Neurol; 2006; 98():91-109. PubMed ID: 16400829 [No Abstract] [Full Text] [Related]
2. T-cell trafficking competence is required for CNS invasion. Lees JR; Archambault AS; Russell JH J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552 [TBL] [Abstract][Full Text] [Related]
3. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters. Laplaud DA; Berthelot L; Miqueu P; Bourcier K; Moynard J; Oudinet Y; Guillet M; Ruiz C; Oden N; Brouard S; Guttmann CR; Weiner HL; Khoury SJ; Soulillou JP J Neuroimmunol; 2006 Aug; 177(1-2):151-60. PubMed ID: 16806500 [TBL] [Abstract][Full Text] [Related]
4. Is natalizumab overshooting its rebound? Fox RJ; Kappos L Neurology; 2008 Mar; 70(13 Pt 2):1073-4. PubMed ID: 18362270 [No Abstract] [Full Text] [Related]
5. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601 [TBL] [Abstract][Full Text] [Related]
6. Thyroid antibodies in aquaporin-4 antibody positive central nervous system autoimmunity and multiple sclerosis. Sellner J; Kalluri SR; Cepok S; Hemmer B; Berthele A Clin Endocrinol (Oxf); 2011 Aug; 75(2):271-2. PubMed ID: 21521293 [No Abstract] [Full Text] [Related]
7. How do immune cells overcome the blood-brain barrier in multiple sclerosis? Larochelle C; Alvarez JI; Prat A FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344 [TBL] [Abstract][Full Text] [Related]
8. T-cell trafficking in the central nervous system. Sallusto F; Impellizzieri D; Basso C; Laroni A; Uccelli A; Lanzavecchia A; Engelhardt B Immunol Rev; 2012 Jul; 248(1):216-27. PubMed ID: 22725964 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. Airas L; Mikkola J; Vainio JM; Elovaara I; Smith DJ J Neuroimmunol; 2006 Aug; 177(1-2):132-5. PubMed ID: 16806498 [TBL] [Abstract][Full Text] [Related]
10. Animal models for multiple sclerosis. Owens T Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828 [No Abstract] [Full Text] [Related]
11. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Rebenko-Moll NM; Liu L; Cardona A; Ransohoff RM Curr Opin Immunol; 2006 Dec; 18(6):683-9. PubMed ID: 17010588 [TBL] [Abstract][Full Text] [Related]
12. [Immune reactions in the central nervous system]. Iivanainen M; Taskinen E Duodecim; 1986; 102(5):281-9. PubMed ID: 3486107 [No Abstract] [Full Text] [Related]
14. Lymphocyte transmigration in the brain: a new way of thinking. Lee BP; Imhof BA Nat Immunol; 2008 Feb; 9(2):117-8. PubMed ID: 18204421 [No Abstract] [Full Text] [Related]
15. [Function of the hemato-encephelic barrier and IgG synthesis in the central nervous system in multiple sclerosis and other neurologic disorders]. Safár J; Vymazal J; Tichý J Cesk Neurol Neurochir; 1986 Nov; 49(6):382-9. PubMed ID: 3802248 [No Abstract] [Full Text] [Related]